Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarctionPrzemysław Mitkowski, Dominik Golicki, Marcin Czech et al.|Kardiologia Polska|2025Cited by 1